| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Epidemiology [L. C., Y. G., Q. W.] and Molecular Genetics [L. L., R. J. L.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, and Arizona Cancer Center, University of Arizona, Tucson, Arizona 85724 [J. E., J. B., D. S. A.]
DNA repair is central to the integrity of the human genome. Reduced DNA repair capacity has been linked to genetic susceptibility to cancer. An adequate expression level of DNA repair genes is essential for normal DNA repair activities. Although there is tissue specificity in the expression, searching for a surrogate tissue is needed for molecular epidemiological studies. In this study, the relative expression levels of five selected human nucleotide excision repair (NER) genes (ERCC1, XPB/ERCC3, XPG/ERCC5, CSB/ERCC6, and XPC) in 20 different types of human normal tissue were simultaneously measured by a new multiplex reverse transcription (RT)-PCR assay using the expression level of the ß-actin gene as an internal control. Transcripts of each of the five NER genes were detectable, but the levels varied in these normal tissues. Both mitogen (phytohemagglutinin)-stimulated and unstimulated human peripheral lymphocytes showed similar expression patterns for the five NER genes. In general, the expression levels of stimulated lymphocytes were also similar to most of the rapidly proliferating tissues, such as the skin, breast, intestine, liver, testis, ovary, placenta, or prostate, but was relatively higher than that of the slowly proliferating or nonproliferating tissues such as adipose, brain, hippocampus, muscle, spleen, or lung. The data suggested that although the five NER genes were expressed at different levels in the normal tissues examined, PHA-stimulated peripheral lymphocytes may be used as a surrogate tissue for estimating expression levels of these genes in proliferating tissues. This new multiplex RT-PCR assay may help detect aberrant expression of these NER genes in both normal and tumor tissues.
This article has been cited by other articles:
![]() |
S. Zienolddiny, D. Campa, H. Lind, D. Ryberg, V. Skaug, L. Stangeland, D. H. Phillips, F. Canzian, and A. Haugen Polymorphisms of DNA repair genes and risk of non-small cell lung cancer Carcinogenesis, March 1, 2006; 27(3): 560 - 567. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pavanello, A. Pulliero, E. Siwinska, D. Mielzynska, and E. Clonfero Reduced nucleotide excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers Carcinogenesis, January 1, 2005; 26(1): 169 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Butkiewicz, O. Popanda, A. Risch, L. Edler, H. Dienemann, V. Schulz, K. Kayser, P. Drings, H. Bartsch, and P. Schmezer Association between the Risk for Lung Adenocarcinoma and a (-4) G-to-A Polymorphism in the XPA Gene Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2242 - 2246. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Popanda, T. Schattenberg, C. T. Phong, D. Butkiewicz, A. Risch, L. Edler, K. Kayser, H. Dienemann, V. Schulz, P. Drings, et al. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer Carcinogenesis, December 1, 2004; 25(12): 2433 - 2441. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Isla, C. Sarries, R. Rosell, G. Alonso, M. Domine, M. Taron, G. Lopez-Vivanco, C. Camps, M. Botia, L. Nunez, et al. Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer Ann. Onc., August 1, 2004; 15(8): 1194 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Vogel, P. Moller, L. Dragsted, S. Loft, A. Pedersen, and B. Sandstrom Inter-individual variation, seasonal variation and close correlation of OGG1 and ERCC1 mRNA levels in full blood from healthy volunteers Carcinogenesis, September 1, 2002; 23(9): 1505 - 1509. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cheng, M. R. Spitz, W. K. Hong, and Q. Wei Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis Carcinogenesis, August 1, 2000; 21(8): 1527 - 1530. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |